Infant Malaria Vaccine Schedule Optimization — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Infant Malaria Vaccine Schedule Optimization — Stella

Home/Malaria Vaccines/

View on ClinicalTrials.gov

Recruiting

Back to Malaria Vaccines trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Burkina Faso

Institut de Recherche en Science de la Santé (IRSS), Bobo-Dioulasso

Groupe de Recherche Action en Santé (GRAS), Ouagadougou

Key details

Phase

Safety & dosing

Sponsor

PATH

Collaborators

Serum Institute of India PVT LTD (SII), Agilis

Enrollment target

~1,200 participants

Started

May 2025

Primary completion

March 2028

Age range

42 Days – 49 Days

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.